OptimizeRx Corp Files 2024 Annual Report
Ticker: OPRX · Form: 10-K · Filed: Mar 20, 2025 · CIK: 1448431
| Field | Detail |
|---|---|
| Company | Optimizerx CORP (OPRX) |
| Form Type | 10-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, 10-K, financials
TL;DR
OptimizeRx filed its 2024 10-K. All good.
AI Summary
OptimizeRx Corp filed its 10-K for the fiscal year ended December 31, 2024, on March 20, 2025. The company, incorporated in Nevada, operates in the business services sector and is headquartered in Waltham, MA. The filing covers its annual report under Section 13 of the Securities Exchange Act of 1934.
Why It Matters
This 10-K filing provides a comprehensive overview of OptimizeRx Corp's financial performance, business operations, and risk factors for the fiscal year 2024, crucial for investors and stakeholders.
Risk Assessment
Risk Level: low — This is a standard annual report filing with no immediate red flags or significant new disclosures.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- March 20, 2025 — Filing Date (The date the 10-K was submitted to the SEC.)
Key Players & Entities
- OptimizeRx Corp (company) — Registrant
- 2024 (date) — Fiscal year end
- March 20, 2025 (date) — Filing date
- Nevada (jurisdiction) — State of incorporation
- Waltham, MA (location) — Principal executive offices
FAQ
What is the primary business of OptimizeRx Corp?
OptimizeRx Corp operates in the Services-Business Services, NEC [7389] sector, as indicated by its Standard Industrial Classification code.
When was OptimizeRx Corp incorporated?
OptimizeRx Corp was incorporated in Nevada.
Where are OptimizeRx Corp's principal executive offices located?
The principal executive offices of OptimizeRx Corp are located at 260 Charles Street, Suite 302, Waltham, MA 02453.
What is the Commission file number for OptimizeRx Corp?
The Commission file number for OptimizeRx Corp is 001-38543.
What type of report is this filing?
This filing is a Form 10-K, which is an annual report under Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 20, 2025 regarding OptimizeRx Corp (OPRX).